Cargando…
Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer
Autores principales: | Xu, Juan, Shao, Tingting, Song, Mingxu, Xie, Yunjin, Zhou, Jialiang, Yin, Jiaqi, Ding, Na, Zou, Haozhe, Li, Yongsheng, Zhang, Jiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357589/ https://www.ncbi.nlm.nih.gov/pubmed/37474972 http://dx.doi.org/10.1186/s12943-023-01821-y |
Ejemplares similares
-
MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer
por: Xu, Juan, et al.
Publicado: (2020) -
FOXP3 Is a HCC suppressor gene and Acts through regulating the TGF-β/Smad2/3 signaling pathway
por: Shi, Jie-Yi, et al.
Publicado: (2017) -
MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor
por: Deng, Xiaochong, et al.
Publicado: (2021) -
Identification and Functional Characterization of Long Non-coding RNA MIR22HG as a Tumor Suppressor for Hepatocellular Carcinoma
por: Zhang, Dong-Yan, et al.
Publicado: (2018) -
TrkB-Induced Inhibition of R-SMAD/SMAD4 Activation is Essential for TGF-β-Mediated Tumor Suppressor Activity
por: Kim, Min Soo, et al.
Publicado: (2020)